Everest Organics Ltd vs Valiant Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Everest Organics Ltd is ₹ 272.15 as of 30 Apr 15:30 . The P/E Ratio of Everest Organics Ltd is 0 as of March 2023 .The P/E Ratio of Valiant Laboratories Ltd is 0 as of March 2023 . The Market Cap of Everest Organics Ltd is ₹ 0 crore as of March 2023 .The Market Cap of Valiant Laboratories Ltd is ₹ 0 crore as of March 2023 . The revenue of Everest Organics Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Valiant Laboratories Ltd for the Dec '25 is ₹ 53.09 crore as compare to the Sep '25 revenue of ₹ 47.07 crore. This represent the growth of 12.79% The ebitda of Everest Organics Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Valiant Laboratories Ltd for the Dec '25 is ₹ -0.26 crore as compare to the Sep '25 ebitda of ₹ 0.94 crore. This represent the decline of -127% The net profit of Everest Organics Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Valiant Laboratories Ltd changed from ₹ -0.51 crore to ₹ -7.06 crore over 7 quarters. This represents a CAGR of 348.88% The Dividend Payout of Everest Organics Ltd changed from 8.75 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Valiant Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Everest Organics Ltd

Everest Organics Limited was incorporated at Hyderabad in February, 1993.
It was promoted by S K Srihari Raju and S K. Chittiramabhadra Raju.
The Company is engaged in manufacturing of Active Pharmaceutical Ingredients and their intermediaries.
The Company commenced its commercial operations in the year 1993.
It set up a plant at Aroor, Andhra Pradesh to manufacture bulk drugs and formulations.

About Valiant Laboratories Ltd

Valiant Laboratories Limited was originally formed as a Partnership Firm as M/s.
Bharat Chemicals' through deed of partnership dated October 17, 1980.
The said Partnership Firm, M/s.
Bharat Chemicals thereafter converted into a Public Company to 'Valiant Laboratories Limited' via Certificate of incorporation dated August 16, 2021 issued by the Central Registration Centre, Registrar of Companies. The Company is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol.
The Company gradually, commenced manufacturing of Paracetamol by late 1982.

FAQs for the comparison of Everest Organics Ltd and Valiant Laboratories Ltd

Which company has a larger market capitalization, Everest Organics Ltd or Valiant Laboratories Ltd?

Market cap of Everest Organics Ltd is 264 Cr while Market cap of Valiant Laboratories Ltd is 428 Cr

What are the key factors driving the stock performance of Everest Organics Ltd and Valiant Laboratories Ltd?

The stock performance of Everest Organics Ltd and Valiant Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Everest Organics Ltd and Valiant Laboratories Ltd?

As of May 3, 2026, the Everest Organics Ltd stock price is INR ₹272.15. On the other hand, Valiant Laboratories Ltd stock price is INR ₹78.85.

How do dividend payouts of Everest Organics Ltd and Valiant Laboratories Ltd compare?

To compare the dividend payouts of Everest Organics Ltd and Valiant Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.